- Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes | Start Date 04-06-2014 | End Date |
Abbreviated Name | Abbreviated Name Ranibizumab 1.65mg/0.165ml inj pre-filled syringes | Start Date 04-06-2014 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 0.165
- UDFS UOM
- ml
- Unit Dose UOM
- pre-filled disposable injection
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravitreal
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.intravitreal
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- S01LA04
- BNF Codes
-
- BNF code 11080200
Code | Start Date | End Date |
---|---|---|
24610711000001100 | 04-06-2014 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Ranibizumab | Based on Ingredient Substance | 10 mg | 1 ml |
Name
Ranibizumab
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10
Strength and UOM (Dmr)
1
Parent Products
-
VTMRanibizumab
-
VMP(Current) Ranibizumab 1.65mg/0.165ml solution ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 pre-filled disposable injection |